Anti-FITC - 70nm Gold NanoUrchins
Cytodiagnostics
SKU:GUAC-70-20-05
Couldn't load pickup availability

Anti-FITC - 70nm Gold NanoUrchins for NanoUrchin-based assays
For protocols centered on FITC-labelled probes and fluorescein-tagged analytes, Anti-FITC - 70nm Gold NanoUrchins provides a focused gold NanoUrchin conjugate for Immunoblotting, Electron Microscopy and Lateral Flow Assay. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Where it helps
Its NanoUrchin morphology supports red-shifted plasmon behavior and enhanced optical response compared with spherical particles of similar core size. This mid-range NanoUrchin size balances visible signal with practical handling in membrane-based and microscopy workflows.
Planning the experiment
- Fits workflows that require clear FITC-labelled probe detection and a reagent choice that can be documented consistently.
- Useful for converting FITC-labelled antibodies, peptides or nucleic-acid probes into a detectable immunoassay signal.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference GUAC-70-20-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. This makes the reagent easier to evaluate during assay planning, troubleshooting and method transfer.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Immunology
- Application:
- Immunoblotting • Electron Microscopy • Lateral Flow Assay
- Reactivity:
- FITC
- Host:
- Sheep
- Clonality:
- Polyclonal
- Isotype:
- IgG
- Formulation:
- 10mM PBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 600nm
- Core Size:
- 70nm
- Shape:
- Urchin
- Material:
- Gold
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.